Notification That Annual Report Will Be Submitted Late (nt 10-k)
01 Março 2023 - 3:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number 000-55535
x Form
10-K ¨ Form 20-F ¨ Form
11-K ¨ Form
10-Q ¨ Form
10-D ¨ Form
N-SAR ¨ Form
N-CSR
For Period Ended: November 30, 2022
PART I: REGISTRANT
INFORMATION
Full Name of Registrant: Q
BioMed Inc.
Address of Principal Executive Office:
c/o Ortoli Rosenstadt LLP
366 Madison Avenue,
3rd Floor
New York, NY 10017
PART II: RULES 12B-25(B)
AND (C)
It is anticipated that the subject Annual
Report on Form 10-K will be filed as soon as feasible.
PART III: NARRATIVE
The Registrant has not completed its Annual
Report on Form 10-k for the period ended November 30, 2022, due to administrative delays.
PART IV: OTHER INFORMATION
|
(1) |
Name and telephone number of person(s) to contact in regard to this notification |
Denis Corin: 212-588-0022
|
(2) |
Have all other periodic reports required under section 13 or 15(d) of the Securities Exchange Act of 1934 or section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Registrant was required to file such report(s) been filed? If the answer is no, identify report(s). |
x YES ¨ NO
|
(3) |
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? |
¨ YES x NO
If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be
made.
Q BioMed Inc. has caused this notification
to be signed on its behalf by the undersigned thereunto duly authorized.
|
Q BioMed Inc. |
|
|
|
Dated: March 1, 2023 |
By: |
/s/ Denis Corin |
|
|
Denis Corin |
|
|
Chief Executive Officer |
Q BioMed (CE) (USOTC:QBIO)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Q BioMed (CE) (USOTC:QBIO)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025